Magnetically therapeutic antibacterial haemostatic wound dressing and preparation method thereof
A hemostatic dressing, magnetic therapy technology, applied in magnetic therapy, electrotherapy, treatment and other directions, can solve problems such as affecting physical health, limited drug absorption, reducing drug effect, etc., to reduce skin deformity and hyperplasia, increase blood circulation, improve effect of treatment
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0031] Example 1
[0032] A magnetic antibacterial hemostatic dressing composed of the following components in parts by weight: 0.5 parts of alginate, 0.5 parts of chitosan, 0.5 parts of crosslinking agent, 0.1 parts of permanent magnet nanoparticles, 0.5 parts of nano-silica, 0.005 parts of growth factor. The alginate is sodium alginate, the crosslinking agent is calcium chloride, the degree of deacetylation of the chitosan is greater than 95%, and the molecular mass is 10,000 to 20,000 Da; the permanent magnet magnetic nanoparticles They are neodymium iron magnetite particles with a magnetic field strength of 0.15-0.35 Tesla; the nano-silica has a pore size of 20-80 μm; and the growth factor is fibroblast growth factor or epidermal cell growth factor.
[0033] A preparation method of a magnetic therapy antibacterial hemostatic dressing includes the following steps:
[0034] S1. Dissolve alginate in purified water, mix and stir for 0.5h~1h to uniformity to prepare solution A; diss...
Example Embodiment
[0040] Example 2
[0041] A magnetic antibacterial hemostatic dressing and a preparation method thereof, which are composed of the following components in parts by weight: 2 parts of alginate, 3 parts of chitosan, 2 parts of crosslinking agent, 1 part of permanent magnet nanoparticles, and nano-dioxide 2 parts of silicon and 0.2 parts of growth factor. The alginate is sodium alginate, the crosslinking agent is calcium chloride, the degree of deacetylation of the chitosan is greater than 95%, and the molecular mass is 10,000 to 20,000 Da; the permanent magnet magnetic nanoparticles They are neodymium iron magnetite particles with a magnetic field strength of 0.15-0.35 Tesla; the nano-silica has a pore size of 20-80 μm; and the growth factor is fibroblast growth factor or epidermal cell growth factor.
[0042] A preparation method of a magnetic therapy antibacterial hemostatic dressing includes the following steps:
[0043] S1. Dissolve alginate in purified water, mix and stir for 0...
Example Embodiment
[0049] Example 3
[0050] A magnetic therapy antibacterial hemostatic dressing and a preparation method thereof, which are composed of the following components in parts by weight: 4 parts of alginate, 6 parts of chitosan, 4 parts of crosslinking agent, 2 parts of permanent magnet nanoparticles, and nano-dioxide Silicon 4 parts, growth factor 0.5 parts. The alginate is sodium alginate, the crosslinking agent is calcium chloride, the degree of deacetylation of the chitosan is greater than 95%, and the molecular mass is 10,000 to 20,000 Da; the permanent magnet magnetic nanoparticles They are neodymium iron magnetite particles with a magnetic field strength of 0.15-0.35 Tesla; the nano-silica has a pore size of 20-80 μm; and the growth factor is fibroblast growth factor or epidermal cell growth factor.
[0051] A preparation method of a magnetic therapy antibacterial hemostatic dressing includes the following steps:
[0052] S1. Dissolve alginate in purified water, mix and stir for 0...
PUM
Property | Measurement | Unit |
---|---|---|
Magnetic field strength | aaaaa | aaaaa |
Aperture | aaaaa | aaaaa |
Particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap